How Effective Is MS Medication Across Racial and Ethnic Groups?
July 18, 2024
July 18, 2024
MINNEAPOLIS, Minnesota, July 18 (TNSres) -- The American Academy of Neurology issued the following news release:
For people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective than teriflunomide at helping people across racial and ethnic groups reach a period of no disease activity. The study is published in the July 17, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. Ofatumu . . .
For people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective than teriflunomide at helping people across racial and ethnic groups reach a period of no disease activity. The study is published in the July 17, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. Ofatumu . . .